Advertisement

Topics

Eagle Pharmaceuticals Announces 11th Patent Issued for Bendeka

07:55 EST 28 Feb 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Bendeka protected by 11 patents running from 2026 through 2033 Ten Orange Book listed patents Eagle Pharmaceuticals, Inc. (Nasdaq:EGRX) (“Eagle” or “the Company”) today announced that the United States Paten...

Other Sources for this Article

Investor Relations for Eagle Pharmaceuticals, Inc.:
Lisa M. Wilson, 212-452-2793
lwilson@insitecony.com

NEXT ARTICLE

More From BioPortfolio on "Eagle Pharmaceuticals Announces 11th Patent Issued for Bendeka"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...